• Je něco špatně v tomto záznamu ?

Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes

EE. Egom, JS. Bae, R. Capel, M. Richards, Y. Ke, RB. Pharithi, V. Maher, P. Kruzliak, M. Lei,

. 2016 ; 419 (1-2) : 83-92. [pub] 20160702

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013731
E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem

Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation of heart function. Previous studies suggest that sphingosine-1-phosphate (S1P), a biologically active sphingomyelin metabolite, regulates Ca(2+) handling in cardiac myocytes, but the underlying mechanism is unclear. In the present study, we tested the hypothesis that S1P-induced functional alteration of intracellular Ca(2+) handling includes the L-type calcium channel current (ICa,L) via a signalling pathway involving P21-activated kinase 1 (Pak1). Our results show that, in rat ventricular myocytes, S1P (100 nM) does not affect the basal activity of ICa,L but is able to partially reverse the effect of the β-adrenergic agonist Isoproterenol (ISO, 100 nM) on ICa,L. S1P (25 nM) also significantly prevents ISO (5 nM)-induced Ca(2+) waves and diastolic Ca(2+) release in these cells. Our further molecular characterisation demonstrates that Pak1 activity is increased in myocytes treated with S1P (25 nM) compared with those myocytes without treatment of S1P. By immunoprecipitation we demonstrate that Pak1 and protein phosphatase 2A (PP2A) are associated in ventricular tissue indicating their functional interaction. Thus the results indicate that S1P attenuates β-adrenergic stress-induced alteration of intracellular Ca(2+) release and L-type Ca(2+) channel current at least in part via Pak1-PP2A-mediated signalling.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013731
003      
CZ-PrNML
005      
20170426114822.0
007      
ta
008      
170413s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11010-016-2752-8 $2 doi
035    __
$a (PubMed)27372350
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Egom, Emmanuel Eroume-A $u Education Division, Department of Clinical Medicine, University of Dublin/Trinity College, Dublin, Ireland. egom@ectrs.ca. Egom Clinical and Translational Research Services Ltd, Halifax, NS, B3H 4R7, Canada. egom@ectrs.ca.
245    10
$a Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes / $c EE. Egom, JS. Bae, R. Capel, M. Richards, Y. Ke, RB. Pharithi, V. Maher, P. Kruzliak, M. Lei,
520    9_
$a Modulation of Ca(2+) homoeostasis in cardiac myocytes plays a major role in beat-to-beat regulation of heart function. Previous studies suggest that sphingosine-1-phosphate (S1P), a biologically active sphingomyelin metabolite, regulates Ca(2+) handling in cardiac myocytes, but the underlying mechanism is unclear. In the present study, we tested the hypothesis that S1P-induced functional alteration of intracellular Ca(2+) handling includes the L-type calcium channel current (ICa,L) via a signalling pathway involving P21-activated kinase 1 (Pak1). Our results show that, in rat ventricular myocytes, S1P (100 nM) does not affect the basal activity of ICa,L but is able to partially reverse the effect of the β-adrenergic agonist Isoproterenol (ISO, 100 nM) on ICa,L. S1P (25 nM) also significantly prevents ISO (5 nM)-induced Ca(2+) waves and diastolic Ca(2+) release in these cells. Our further molecular characterisation demonstrates that Pak1 activity is increased in myocytes treated with S1P (25 nM) compared with those myocytes without treatment of S1P. By immunoprecipitation we demonstrate that Pak1 and protein phosphatase 2A (PP2A) are associated in ventricular tissue indicating their functional interaction. Thus the results indicate that S1P attenuates β-adrenergic stress-induced alteration of intracellular Ca(2+) release and L-type Ca(2+) channel current at least in part via Pak1-PP2A-mediated signalling.
650    _2
$a zvířata $7 D000818
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a vápníkové kanály - typ L $x metabolismus $7 D020746
650    _2
$a vápníková signalizace $x účinky léků $7 D020013
650    _2
$a srdeční komory $x metabolismus $7 D006352
650    _2
$a intracelulární signální peptidy a proteiny $x metabolismus $7 D047908
650    _2
$a lysofosfolipidy $x farmakologie $7 D008246
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a kardiomyocyty $x metabolismus $7 D032383
650    _2
$a proteinfosfatasa 2 $x metabolismus $7 D054648
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a sfingosin $x analogy a deriváty $x farmakologie $7 D013110
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bae, James S H $u Department of Pharmacology, University of Oxford, Oxford, UK.
700    1_
$a Capel, Rebecca $u Department of Pharmacology, University of Oxford, Oxford, UK.
700    1_
$a Richards, Mark $u Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
700    1_
$a Ke, Yunbo $u Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, USA.
700    1_
$a Pharithi, Rebabonye B $u Heart Efficiency Unit, Cardiology Department, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland.
700    1_
$a Maher, Vincent $u Heart Efficiency Unit, Cardiology Department, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland.
700    1_
$a Kruzliak, Peter $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho tr 1946/1, 656 91, Brno, Czech Republic. kruzliakpeter@gmail.com.
700    1_
$a Lei, Ming $u Department of Pharmacology, University of Oxford, Oxford, UK. ming.lei@pharm.ox.ac.uk.
773    0_
$w MED00003385 $t Molecular and cellular biochemistry $x 1573-4919 $g Roč. 419, č. 1-2 (2016), s. 83-92
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27372350 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426115140 $b ABA008
999    __
$a ok $b bmc $g 1200196 $s 974509
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 419 $c 1-2 $d 83-92 $e 20160702 $i 1573-4919 $m Molecular and cellular biochemistry $n Mol Cell Biochem $x MED00003385
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...